Your browser doesn't support javascript.
loading
Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia.
Murphy, Tracy; Zou, Jinfeng; Arruda, Andrea; Wang, Ting Ting; Zhao, Zhen; Zheng, Yangqiao; Gupta, Vikas; Maze, Dawn; McNamara, Caroline; Minden, Mark D; Schimmer, Aaron; Sibai, Hassan; Yee, Karen; Capo-Chichi, Jose-Mario; Stockley, Tracy; Schuh, Andre; Bratman, Scott V; Chan, Steven M.
Afiliación
  • Murphy T; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
  • Zou J; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
  • Arruda A; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
  • Wang TT; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
  • Zhao Z; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
  • Zheng Y; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
  • Gupta V; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
  • Maze D; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
  • McNamara C; Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
  • Minden MD; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
  • Schimmer A; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
  • Sibai H; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
  • Yee K; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
  • Capo-Chichi JM; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON.
  • Stockley T; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON.
  • Schuh A; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
  • Bratman SV; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
  • Chan SM; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario. steven.chan@uhnresearch.ca.
Haematologica ; 109(2): 671-675, 2024 Feb 01.
Article en En | MEDLINE | ID: mdl-37345484
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Isocitrato Deshidrogenasa Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Isocitrato Deshidrogenasa Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article